Please login to the form below

Not currently logged in
Email:
Password:

Type 2 diabetes market set to soar to $64bn by 2026

Rising prevalence, progressive nature and diagnosis of the condition behind the surge

money

The type 2 diabetes market is set to surge, rising from $28.6bn in 2016 to an estimated $64bn in 2026.

The seven major markets of the US, France, Germany, Italy, Spain, UK and Japan are expected to see 8.4% compound annual growth, driven by the condition’s rising prevalence, progressive nature and diagnosis.

The rise in disease-related comorbidities will also play a part in the projected market boost as more patients require multiple drug therapies, according to research and analysis group GlobalData.

Managing healthcare analyst Jesus Cuaron said: “All currently available treatments for type 2 diabetes are initially effective and reduce complication rates, but they lack the ability to maintain glycaemic control in the long term because of the progressive nature of pancreatic B-cell dysfunction.

“This represents one of the highest unmet needs in the type 2 diabetes space and demonstrates that the market has a significant growth opportunity for new patent-protected products that successfully address underlying disease pathology, cardiovascular concerns or compliance issues.”

Article by
Gemma Jones

17th August 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics